Exponent, Inc. (EXPO) AI Stock Analysis

Exponent, Inc. is a science and engineering consulting firm operating through two core segments: Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services such as biomechanics, civil and electrical engineering, materials science, construction consulting, and data sciences. The Environmental and Health segment focuses on chemical regulation, ecological sciences, environmental sciences, and health sciences, handling issues related to food safety, sustainability, and health risks. Headquartered in Menlo Park, California, Exponent integrates approximately 90 technical disciplines to serve clients in energy, consumer products, technology, transportation, and government sectors.

From FY2022 to FY2025, Exponent generated a 5-year revenue CAGR of 2.5%. Annual revenue reached $536.8M in FY2023 with net income of $100.3M, rising to $558.5M in revenue and $109.0M in net income in FY2024. In FY2025, revenue increased 4.2% to $582.0M, while net income totaled $106.0M, generating an operating margin of 20.6% and a net margin of 18.2%. In the trailing twelve months ending June 30, 2026, revenue stood at $567.1M with an operating margin of 18.8% and EPS of $2.23. For the latest quarter ending June 30, 2026, quarterly revenue grew 12.0% year-over-year while quarterly earnings expanded 15.7%.

As of June 30, 2026, Exponent held $66.6M in cash and short-term investments alongside total debt of $80.7M, resulting in net debt of $14.1M. The company maintains a current ratio of 1.98 and a debt-to-equity ratio of 0.28 against shareholders' equity of $288.6M. In FY2025, Exponent generated $131.7M in operating cash flow and $122.3M in free cash flow. Capital allocation in FY2025 included $9.4M in capital expenditures, $61.5M in dividends paid, and $97.1M directed toward share buybacks.

Exponent trades at a trailing P/E of 32.2x and a forward P/E of 31.5x, above the median of its US-listed Industrials peers of 24.8x and 17.2x, respectively. Its enterprise value of $3.13B reflects an EV/EBITDA multiple of 23.6x, compared to the peer median of 13.9x, while its price-to-sales ratio of 6.0x compares to the peer median of 1.5x. Over the past year, EXPO delivered a return of 7.2%, trailing the S&P 500 return of 16.8%. Over a 5-year span, EXPO returned -30.9% compared to 83.0% for the S&P 500.

Exponent pays a quarterly dividend with an annual forward payout of $1.23 per share, yielding 1.71%. Its payout ratio stands at 55.2%, supported by 14 consecutive years of dividend payments. Over the past 5 years, dividends grew at an annualized rate of 9.6%. The company's last ex-dividend date was September 4, 2026.

Wall Street analysts maintain 2 Strong Buy, 1 Buy, and 1 Hold ratings on Exponent, with zero Sell or Strong Sell ratings. The mean price target is $84.00, representing a 16.9% upside from the last close of $71.85. For the fiscal year ending December 31, 2026, consensus estimates project revenue of $612.1M and EPS of $2.41, reflecting 16.4% EPS growth. Over the last four quarters, Exponent beat EPS expectations 3 times. The next earnings date is October 29, 2026.

This page is an AI-written research summary of Exponent, Inc. (EXPO). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: EXPO income statement, EXPO balance sheet, EXPO key metrics, EXPO analyst forecast, EXPO chart. See the EXPO stock overview for the latest quote and news.